<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sun, 12 Apr 2026 00:20:19 -0400--><rss version="2.0">
    <channel>
        <title>Intensity Therapeutics, Inc. (INTS) SEC Filings</title>
        <link>https://ir.intensitytherapeutics.com/sec-filings/quarterly-reports/rss</link>
        <description>Intensity Therapeutics, Inc. (INTS) - Quarterly Reports</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/intensitytherapeutics/files/theme/images/logo-sm.png</url>
                <title>Intensity Therapeutics, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-25-000103/0001567264-25-000103.pdf</link>
                <pubDate>Thu, 06 Nov 25 16:02:22 -0500</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-25-000103/0001567264-25-000103.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-25-000077/0001567264-25-000077.pdf</link>
                <pubDate>Thu, 07 Aug 25 16:02:55 -0400</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-25-000077/0001567264-25-000077.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-25-000039/0001567264-25-000039.pdf</link>
                <pubDate>Tue, 13 May 25 16:02:59 -0400</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-25-000039/0001567264-25-000039.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-24-000052/0001567264-24-000052.pdf</link>
                <pubDate>Wed, 13 Nov 24 16:02:51 -0500</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-24-000052/0001567264-24-000052.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[6 Related Documents: 10-Q, EX-10.1, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-24-000041/0001567264-24-000041.pdf</link>
                <pubDate>Thu, 08 Aug 24 16:14:27 -0400</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-24-000041/0001567264-24-000041.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-24-000010/0001567264-24-000010.pdf</link>
                <pubDate>Thu, 09 May 24 16:02:29 -0400</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-24-000010/0001567264-24-000010.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001213900-23-085791/0001213900-23-085791.pdf</link>
                <pubDate>Mon, 13 Nov 23 12:13:32 -0500</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001213900-23-085791/0001213900-23-085791.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q/A - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q/A, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001213900-23-067270/0001213900-23-067270.pdf</link>
                <pubDate>Mon, 14 Aug 23 18:01:57 -0400</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001213900-23-067270/0001213900-23-067270.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001213900-23-066740/0001213900-23-066740.pdf</link>
                <pubDate>Mon, 14 Aug 23 12:46:39 -0400</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001213900-23-066740/0001213900-23-066740.pdf</guid>
                                                                            </item>
            </channel>
</rss>